BioSpace News Archive

Virica Biotech Inc., a leading developer of cell enhancers for scaling of viral vector as well as cell and gene therapy manufacturing will expand its bioprocessing services through a partnership with Carleton University.

Vertex Announces US FDA Approval of CASGEVY ™ (exagamglogene autotemcel) for the Treatment of Transfusion-Dependent Beta Thalassemia.

Nurix Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for NX-5948, a highly selective degrader of Bruton’s tyrosine kinase (BTK), for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia.

CRISPR Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 gene-edited cell therapy.

Masimo (NASDAQ: MASI) announced today that Bob Chapek has been appointed to Masimo’s Board of Directors.

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, announced the grant of inducement awards to two employees on January 12, 2024 in connection with the employees’ commencement of employment at CymaBay.

Arcus Biosciences, Inc. (NYSE:RCUS) today announced promising overall survival data from ARC-8, a Phase 1b study that is being co-developed with Gilead Sciences.

Aster Insights today announced the company and members of the Oncology Research Information Exchange Network® (ORIEN) will be presenting at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, which will be held January 18-20, 2024 in San Francisco, CA.

Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2024, ended December 31, 2023, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on January 31, 2024.

Envista Holdings Corporation (NYSE: NVST) today announced that the company will hold an Investor Event at the Envista Summit on Friday, February 16, from 8:00 a.m. to 10:45 a.m. PST.